CRScube hosts first breakout session on Japanese post-marketing surveillance (JPMS) enhancements

CRScube held its first breakout session dedicated to Japanese Post-Marketing Surveillance (JPMS) on 15th October 2024.

The session was attended by pharmaceutical companies and CROs who are users of cubeCDMS's JPMS functions. It included practical discussions about CRScube’s JPMS functions and a presentation by Seven to One, Inc. about solutions to problems in PMS tasks, advantages and improvements of JPMS functions, and an introduction and demo of automated workflows.

After such a successful event, we will develop this concept further to work closer with our clients in Japan.

Share via

See CRScube in action

Book a demo

Explore how our platform will elevate your team and clinical trial management.

Get insights straight to your inbox

Explore our knowledge base

Stay in-the-know with regular updates and industry opinions from our expert team.

See all resources

Featured resources

Modern safety reporting in a legacy world – How cubeSAFETY compares, according to CRScube’s COO

Safety reporting is moving beyond simple adverse event collection. The future lies in intelligent risk detection and frictionless data capture.

Electronic safety reporting in clinical trials: What sponsors need to know

For sponsors and CROs, it is crucial to understand the implications of the full enforcement of ICH E2B(R3) standards, especially as it impacts both pre- and post-authorization submissions.